By partnering uniquely with venture capital, Wheeler helps to ease the translational process from discovery to clinic for clients in biologics innovation. Founded by Dr. Jesse McCool, Christian Kanady of Echo, and Errik Anderson of Alloy Therapeutics and 82VS in 2021, the first-in-class CDMO was designed to provide accelerative development services to biotech startups and emerging biopharma innovators at a fair price.
Wheeler Bio announces oversubscribed Series A-1, plans for expansion and continued growth
The financing will broaden Wheeler’s capabilities, paving the way for future growth and planned build-out of a 52,000 square foot manufacturing facility.